BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quijia Quezada C, Azevedo CS, Charneau S, Santana JM, Chorilli M, Carneiro MB, Bastos IMD. Advances in nanocarriers as drug delivery systems in Chagas disease. Int J Nanomedicine 2019;14:6407-24. [PMID: 31496694 DOI: 10.2147/IJN.S206109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Muraca G, Berti IR, Sbaraglini ML, Fávaro WJ, Durán N, Castro GR, Talevi A. Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Front Chem 2020;8:601151. [PMID: 33324615 DOI: 10.3389/fchem.2020.601151] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Choudhury SD. Nano-Medicines a Hope for Chagas Disease! Front Mol Biosci 2021;8:655435. [PMID: 34141721 DOI: 10.3389/fmolb.2021.655435] [Reference Citation Analysis]
3 Li X, Yi S, Scariot DB, Martinez SJ, Falk BA, Olson CL, Romano PS, Scott EA, Engman DM. Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection. JCI Insight 2021;6:145523. [PMID: 33986194 DOI: 10.1172/jci.insight.145523] [Reference Citation Analysis]
4 Souri M, Soltani M, Moradi Kashkooli F, Kiani Shahvandi M. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles. J Control Release 2021;341:227-46. [PMID: 34822909 DOI: 10.1016/j.jconrel.2021.11.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
5 de Lacerda Coriolano D, de Souza JB, Bueno EV, Medeiros SMFRDS, Cavalcanti IDL, Cavalcanti IMF. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains. Braz J Microbiol 2021;52:267-78. [PMID: 33231865 DOI: 10.1007/s42770-020-00406-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Arrua EC, Hartwig O, Loretz B, Goicoechea H, Murgia X, Lehr CM, Salomon CJ. Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy. Colloids Surf B Biointerfaces 2022;217:112678. [PMID: 35816885 DOI: 10.1016/j.colsurfb.2022.112678] [Reference Citation Analysis]
7 Pardo-Rodriguez D, Lasso P, Mateus J, Mendez J, Puerta CJ, Cuéllar A, Robles J, Cuervo C. A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cru zi activity and induces T cell cytokine production. Heliyon 2022;8:e09182. [PMID: 35368545 DOI: 10.1016/j.heliyon.2022.e09182] [Reference Citation Analysis]